Skip to content

Compression Garments on Hypermobility Type of Ehlers-Danlos Syndrome (CGhEDS)

Compression Garments Effects on Postural Balance of Patients With Hypermobility Type of Ehlers-danlos Syndrome, a Prospective Study on 40 Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03359135
Acronym
VECO
Enrollment
40
Registered
2017-12-02
Start date
2018-04-01
Completion date
2019-04-30
Last updated
2018-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypermobility Type Ehlers-Danlos Syndrome

Keywords

Compression garment

Brief summary

This study evaluates the effects of wearing a compression garment on the postural balance of patients with hypermobility type of Ehlers-Danlos syndrome, in randomised controlled study.

Interventions

OTHERRehabilitation

Rehabilitation during 4 weeks

Rehabilitation associated to wearing CG during 4 weeks

Sponsors

Hôpital Raymond Poincaré
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥16 years * hEDS with the 2017 diagnostic criteria . * A normal neurological examination with no sensory disorders, no cerebellar syndrome or vestibular syndrome. * An optimal balanced analgesic treatment before inclusion * Patients who have not modified their physical treatment (physiotherapy) since 6 months.

Exclusion criteria

* Surgery of the lower limb (hip, knee or ankle) * Patient having already wear compression garments in the year preceding. * Neurological history of sensory , vestibular or cerebellar disorders.

Design outcomes

Primary

MeasureTime frameDescription
Centre of pression speed4 weeksa stability parameter on a force plate

Countries

France

Contacts

Primary ContactBENISTAN Karelle, Dr
karelle.benistan@aphp.fr0033147104440
Backup ContactGADER Nadra, Dr
nadra.gd@gmail.com0033788127902

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026